Nabriva
Therapeutics operates as a biopharmaceutical company, discovers and develops of antibiotics... Read moreNabriva
Therapeutics operates as a biopharmaceutical company, discovers and develops of antibiotics... Read more
News
Jul 25, 2024
Drug Store News
Nabriva: Meitheal Pharmaceuticals acquires Contepo from Nabriva Therapeutics
Oct 21, 2023
Owler
Nabriva Therapeutics plc: Nabriva's revenue changed from $36.51M in Mar 2023 to $29.56M in Jun 2023
Jul 24, 2023
MarketScreener
Nabriva: Nabriva Therapeutics : Failure to Satisfy Listing Rule - Form 8-K
May 23, 2023
Owler
Nabriva Therapeutics plc: Nabriva's revenue changed from $36.94M in Dec 2022 to $36.51M in Mar 2023
Apr 18, 2023
Owler
Nabriva Therapeutics plc: Nabriva's revenue changed from $35.62M in Sep 2022 to $36.94M in Dec 2022
Feb 06, 2023
MarketScreener
Nabriva: Nabriva Therapeutics : Material Agreement - Form 8-K
Jan 07, 2023
Life Care News
Nabriva: Nabriva Therapeutics Provides Corporate Update
Jan 06, 2023
Endpoints News
Nabriva: An antibiotics biotech begins wind down, lays off nearly all workers
Nov 28, 2022
Nasdaq
Nabriva: Nabriva Announces Positive Results From Phase 1 Trial Of Lefamulin In Cystic Fibrosis; Stock Up
Nov 28, 2022
MarketWatch
Nabriva: Nabriva's stock is up after sharing antibiotic news
Nabriva Competitors
1
2
3
4
5
6
7
8
9
10